Tuberculosis preventive therapy for people living with HIV: A systematic review and network meta-analysis.

PLoS Medicine
Mercedes Yanes-LaneDick Menzies

Abstract

Tuberculosis (TB) preventive therapy (TPT) is an essential component of care for people living with HIV (PLHIV). We compared efficacy, safety, completion, and drug-resistant TB risk for currently recommended TPT regimens through a systematic review and network meta-analysis (NMA) of randomized trials. We searched MEDLINE, Embase, and the Cochrane Library from inception through June 9, 2020 for randomized controlled trials (RCTs) comparing 2 or more TPT regimens (or placebo/no treatment) in PLHIV. Two independent reviewers evaluated eligibility, extracted data, and assessed the risk of bias. We grouped TPT strategies as follows: placebo/no treatment, 6 to 12 months of isoniazid, 24 to 72 months of isoniazid, and rifamycin-containing regimens. A frequentist NMA (using graph theory) was carried out for the outcomes of development of TB disease, all-cause mortality, and grade 3 or worse hepatotoxicity. For other outcomes, graphical descriptions or traditional pairwise meta-analyses were carried out as appropriate. The potential role of confounding variables for TB disease and all-cause mortality was assessed through stratified analyses. A total of 6,466 unique studies were screened, and 157 full texts were assessed for eligibility....Continue Reading

References

Oct 31, 2001·AIDS·J L JohnsonUNKNOWN Uganda-Case Western Reserve University Research Collaboration
Sep 5, 2002·Statistics in Medicine·Thomas Lumley
Sep 10, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Fred M GordinUNKNOWN Centers for Disease Control and Prevention
Jul 8, 2011·The New England Journal of Medicine·Neil A MartinsonRichard E Chaisson
Jul 8, 2011·The New England Journal of Medicine·Shabir A MadhiUNKNOWN P1041 Study Team
Mar 19, 2013·BMC Medical Research Methodology·Ulrike KrahnJochem König
Mar 19, 2014·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Jeroen P JansenGeorgia Salanti
Mar 29, 2014·The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·D M GrayH J Zar
Nov 5, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jonathan E GolubRichard E Chaisson
Dec 1, 2012·Research Synthesis Methods·Gerta Rücker
Jul 21, 2015·The New England Journal of Medicine·UNKNOWN TEMPRANO ANRS 12136 Study GroupXavier Anglaret
Aug 1, 2015·BMC Medical Research Methodology·Gerta Rücker, Guido Schwarzer
Jun 1, 2016·AIDS·Timothy R SterlingUNKNOWN Tuberculosis Trials Consortium, the AIDS Clinical Trials Group for the PREVENT TB Trial (TBTC Study 26ACTG 5259) The investi
Apr 14, 2017·Systematic Reviews·L MbuagbawGordon H Guyatt
Jul 21, 2017·The New England Journal of Medicine·James HakimUNKNOWN REALITY Trial Team
Jul 26, 2017·AIDS·Gregory P BissonUNKNOWN Adult AIDS Clinical Trials Group A5274 (REMEMBER) Study Team
Feb 7, 2018·Journal of Acquired Immune Deficiency Syndromes : JAIDS·McNeil NgongondoUNKNOWN AIDS Clinical Trials Group A5274 (REMEMBER) Study Team
Feb 8, 2018·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Kristina M BrooksParag Kumar
Mar 8, 2018·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Frank A PostUNKNOWN Reduction of EArly mortaLITY in HIV-infected adults and children starting antiretroviral therapy (REALITY) Trial Team
Mar 14, 2019·The New England Journal of Medicine·Susan SwindellsUNKNOWN BRIEF TB/A5279 Study Team
Aug 30, 2019·BMJ : British Medical Journal·Jonathan A C SterneJulian P T Higgins
Oct 3, 2019·The New England Journal of Medicine·Amita GuptaUNKNOWN IMPAACT P1078 TB APPRISE Study Team
Feb 14, 2020·MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports·Timothy R SterlingRobert Belknap
Aug 14, 2020·The Journal of Antimicrobial Chemotherapy·Tom G JacobsUNKNOWN WHO Paediatric Antiretroviral Working Group

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Related Papers

Journal of the International AIDS Society
Lucia González FernándezSusan Swindells
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease
Saskia Den BoonHaileyesus Getahun
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease
I PathmanathanJ S Cavanaugh
Current Opinion in HIV and AIDS
Betina Durovni, Solange C Cavalcante
© 2021 Meta ULC. All rights reserved